In the News

1855 News Items found
Pictured: Emily Foley
Profile
At Work: Cell Biologist Emily Foley
Memorial Sloan Kettering cell biologist Emily Foley discusses her research, which is focused on improving the understanding of cell division.
Mouse glioblastoma tumor with phagocytic macrophages
In the Lab
Memorial Sloan Kettering researchers say a drug that acts on noncancerous, tumor-infiltrating cells might provide a new treatment option for the most common and aggressive type of brain cancer.
Pictured: James E. Rothman, Thomas C. Südhof & Randy W. Schekman
Honors
James Rothman, who receives this year’s Nobel Prize in Physiology or Medicine together with Randy Schekman and Thomas Südhof, conducted more than a decade of his seminal research at Memorial Sloan Kettering.
Breast cancer mosaic
Snapshot
Memorial Sloan Kettering scientists are developing new imaging instrumentation that could enable pathologist and surgeons to collaborate more seamlessly and reduce the need for repeat surgeries.
Pictured: Pseudomonas aeruginosa
Snapshot
Memorial Sloan Kettering researchers have discovered how a common bacterium can evolve to become more mobile and easier to get rid of.
Pictured: Daniel Thorek & Jan Grimm
In the Lab
A new imaging approach being investigated by Memorial Sloan Kettering researchers could provide better information about a tumor’s molecular activity, allowing for a more accurate diagnosis.
Donna Handley
Announcement
Hartford Healthcare system in Connecticut has been selected as the first MSK Cancer Alliance member, established to enhance delivery of care, improve patient outcomes, and advance research.
Pictured: Derek Tan
Q&A
In this Q&A, Memorial Sloan Kettering chemist Derek Tan discusses why natural products offer inspiration for the development of new drugs.
Pictured: Kenneth Offit
In the Lab
Researchers have found the first evidence that susceptibility to developing acute lymphoblastic leukemia during childhood may be heritable.
Pictured: Cancer cell lines
In the Lab
A recent study found that the cell lines most commonly used for research on ovarian cancer are not the most suitable.